Meeting to be held in New York on April 18 hosted by Piper Sandler.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INZY:
- Inozyme price target lowered to $14 from $16 at BofA
- Inozyme price target lowered to $14 from $16 at H.C. Wainwright
- Inozyme Pharma Advances with Promising INZ-701 Trial Results
- Inozyme announces ‘positive’ results from Phase 1/2 trials of INZ-701
- Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency